# Haleon plc Haleon plc is a **British multinational consumer healthcare company** headquartered in Weybridge, England.Haleon has quickly risen to become one of the largest consumer healthcare businesses in the world. ## Key Information - **Industry**: Healthcare and Consumer Goods - **Headquarters**: Weybridge, Surrey, England - **Area Served**: Worldwide - **Key People**: Dave Lewis (Chairman), Brian McNamara (CEO) - **Products**: Oral hygiene and medicines, nutritional products, over-the-counter medicines - **Revenue**: £11,302 million (2023) - **Operating Income**: £1,996 million (2023) - **Net Income**: £1,111 million (2023) - **Total Assets**: £34,055 million (2023) - **Total Equity**: £16,729 million (2023) - **Number of Employees**: 24,000 (2023) ## Brands and Products Haleon's portfolio includes a variety of well-known brands such as: - **Oral Health**: Sensodyne, Parodontax, Aquafresh - **Pain Relief**: Panadol, Advil - **Vitamins and Supplements**: Centrum - **Respiratory and Digestive Products**: Theraflu, Tums ## Market Presence Haleon operates with a significant global presence, offering products across **120 markets**. The company is a leader in over-the-counter medicines with a **7.3 percent market share**. ## Governance and Operations The company's governance is overseen by a Board of Directors responsible for the long-term success of Haleon. The Board delegates specific areas of governance to its Audit & Risk, Environmental & Social Sustainability, Nominations & Governance, and Remuneration Committees. ## Commitment to Health With a purpose to deliver better everyday health with humanity, Haleon's approach combines **science, innovation, and human understanding**. Their brands are trusted by millions globally, reflecting the company's commitment to improving health and well-being.